Overview

MSC for Treatment of cGVHD After Allo-HSCT

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of mesenchymal stem cells in patients with chronic graft-versus-host disease.
Phase:
Phase 2
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Peking University People's Hospital
Sun Yat-sen University
Xinqiao Hospital, Army Medical University
Treatments:
Cyclosporine
Cyclosporins
Glucocorticoids